Retrieve available abstracts of 6 articles: HTML format
Single Articles
April 2025
BIRABAHARAN M Vancomycin-Resistant Enterococci-Active Perioperative Prophylaxis for Liver
Transplant Patients Requires Attention to the Gut Microbiota.
Clin Infect Dis. 2025 Apr 22:ciaf168. doi: 10.1093. PubMed
March 2025
BURASTERO GJ, Wey EQ, Guidetti V, Cantergiani S, et al Impact of VRE-active perioperative prophylaxis in liver transplant patients
colonized by Vancomycin-Resistant Enterococci.
Clin Infect Dis. 2025 Mar 14:ciaf121. doi: 10.1093. PubMedAbstract available
February 2024
KITT E, Stephens-Shields AJ, Huang YV, Bitterman T, et al The Comparative Effectiveness of Perioperative Antibiotic Regimens to Prevent
Surgical Site Infections in Pediatric Liver Transplant Recipients.
Clin Infect Dis. 2024 Feb 21:ciae095. doi: 10.1093. PubMedAbstract available
January 2024
YATES TA, Halliday N Re: Association of CMV DNAemia with Long-Term Mortality in a Randomized Trial of
Preemptive Therapy (PET) and Antiviral Prophylaxis (AP) for Prevention of CMV
Disease in High-Risk Donor Seropositive, Recipient Seronegative (D+R-) Liver
Transplant Reci
Clin Infect Dis. 2024 Jan 9:ciae004. doi: 10.1093. PubMed
KUMAR L, Dasgupta S, Murray-Krezan C, Singh N, et al Response to Yates and Halliday regarding CMV DNAemia and time-to-mortality in a
Randomized Trial of PET vs AP in CMV D+R-Liver Transplant Recipients.
Clin Infect Dis. 2024 Jan 8:ciae005. doi: 10.1093. PubMed
October 2023
KUMAR L, Dasgupta S, Murray-Krezan C, Singh N, et al Association of CMV DNAemia with Long-Term Mortality in a Randomized Trial of
Preemptive Therapy (PET) and Antiviral Prophylaxis (AP) for Prevention of CMV
Disease in High-Risk Donor Seropositive, Recipient Seronegative (D+R-) Liver
Transplant Recipien
Clin Infect Dis. 2023 Oct 20:ciad643. doi: 10.1093. PubMedAbstract available
